Decreased serum cell-free DNA levels in rheumatoid arthritis

Autoimmunity Highlights

Volumn 6, Issue 1-2, 2015, Pages 23-30

  Dunaeva, Marina ^a   Buddingh’, Bastiaan C ^a   Toes, René E M ^b   Luime, Jolanda J ^c   Lubberts, Erik ^c   Pruijn, Ger J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmune diseases; Biomarker; Cell free DNA; Rheumatoid arthritis

Indexed keywords

BETA ACTIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DEOXYRIBONUCLEASE; EXTRACELLULAR DNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENZYME ACTIVITY; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PHYSICAL PARAMETERS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SINGLE RADIAL ENZYME DIFFUSION;

EID: 84939226164     PISSN: 20380305     EISSN: 20383274     Source Type: Journal    
DOI: 10.1007/s13317-015-0066-6     Document Type: Article

References (37)

1. van Venrooij WJ, van Beers J, Pruijn GJ (2011) Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 7:391–398
2. Steiner G (2007) Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clin Rev Allergy Immunol 32:23–36
3. Niienhuis S, Zendman A, Vossenaar E, Pruijn G, van Venrooij W (2004) Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 350:17–34
4. Landewe R (2003) The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing. Arthritis Rheum 48:1–5
5. Gauthier V, Tyler L, Mannik M (1996) Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol 156:1151–1156
6. Lo Y, Zhang J, Leung T, Lau T, Chang AM, Hjelm NM (1999) Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64:218–224
7. Rainer T, Wong L, Lam W, Yuen E, Lam NY, Metreweli C et al (2003) Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 49:562–569
8. Geiger S, Holdenrieder S, Stieber P, Hamann GF, Bruening R, Ma J et al (2006) Nucleosomes in serum of patients with early cerebral stroke. Cerebrovasc Dis 21:32–37
9. Chang C, Chia R, Wu T, Tsao K, Sun C, Wu J (2003) Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta 327:95–101
10. Rhodes A, Wort S, Thomas H, Collinson P, Bennett E (2006) Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 10:R60
11. Gornik I, Wagner J, Gasparović V, Lauc G, Gornik O (2009) Free serum DNA is an early predictor of severity in acute pancreatitis. Clin Biochem 42:38–43
12. Schwarzenbach H, Hoon D, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426–437
13. Dawson S, Tsui D, Murtaza M, Biggs H, Rueda OM, Chin SF et al (2013) Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 368:1199–1209
14. Perkins G, Yap T, Pope L, Cassidy AM, Dukes JP, Riisnaes R et al (2012) Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers. PLoS One 7:e47020
15. Galeazzi M, Morozzi G, Piccini M, Chen J, Bellisai F, Fineschi S et al (2003) Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders. Autoimmun Rev 2:50–55
16. Bartoloni E, Ludovini V, Alunno A, Pistola L, Bistoni O, Crino L et al (2011) Increased levels of circulating DNA in patients with systemic autoimmune diseases: a possible marker of disease activity in Sjögren’s syndrome. Lupus 20:928–935
17. Zhong X, von Mühlenen I, Li Y, Kang A, Gupta AK, Tyndall A et al (2007) Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis. Clin Chem 53:1609–1614
18. de Rooy D, van der Linden M, Knevel R, Huizinga T, van der Helm-van Mil A (2011) Predicting arthritis outcomes—what can be learned from the Leiden early arthritis clinic? Rheumatology 50:93–100
19. Umetani N, Kim J, Hiramatsu S, Reber H, Hines O, Bilchik A (2006) Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem 52:1062–1069
20. Huang Z, Hua D, Hu Y, Cheng Z, Zhou X, Xie Q et al (2012) Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma. Pathol Oncol Res 18:271–276
21. Chitrabamrung S, Bannett J, Rubin R, Tan E (1981) A radial diffusion assay for plasma and serum deoxyribonuclease I. Rheumatol Int 1:49–53
22. Ohmura K, Terao C, Maruya E, Katayama M, Matoba K, Shimada K et al (2010) Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis. Rheumatology 49:2298–2304
23. Seegobin S, Ma M, Dahanayake C, Cope AP, Scott DL, Lewis CM et al (2014) ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial. Arthritis Res Ther 16:R13
24. Shakhmaeva I, Saifullina D, Sattarova L, Abdullin T (2011) Electrochemical sensor for blood deoxyribonucleases: design and application to the diagnosis of autoimmune thyroiditis. Anal Bioanal Chem 401:2591–2597
25. Napirei M, Ricken A, Eulitz D, Knoop H, Mannherz H (2004) Expression pattern of the deoxyribonuclease 1 gene: lessons from the Dnase1 knockout mouse. Biochem J 380:929–937
26. Jørgensen M, Rekvig O, Jacobsen R, Jacobsen S, Fenton K (2011) Circulating levels of chromatin fragments are inversely correlated with anti-dsDNA antibody levels in human and murine systemic lupus erythematosus. Immunol Lett 138:179–186
27. D’Auria F, Rovere-Querini P, Giazzon M, Ajello P, Baldissera E, Manfredi AA et al (2004) Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies. J Intern Med 255:409–418
28. Leon S, Ehrlich G, Shapiro B, Labbate V (1977) Free DNA in the serum of rheumatoid arthritis patients. J Rheumatol 4:139–143
29. Sjoholm M, Hoffmann G, Lindgren S, Dillner J, Carlson J (2005) Comparison of archival plasma and formalin-fixed paraffin-embedded tissue for genotyping in hepatocellular carcinoma. Cancer Epidemiol Biomark Prev 14:251–255
30. Beck J, Urnovitz HB, Riggert J, Clerici M, Schütz E (2009) Profile of the circulating DNA in apparently healthy individuals. Clin Chem 55:730–738
31. Stroun M, Lyautey J, Lederrey C, Mulcahy HE, Anker P (2001) Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells? Ann N Y Acad Sci 945:258–264
32. Lui Y, Chik K, Chiu R, Ho C, Lam C, Lo Y (2002) Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48:421–427
33. Smoleńska Z, Kaznowska Z, Zarówny D, Simmonds HA, Smoleński R (1999) Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis. Rheumatology 38:997–1002
34. Hyrich K, Silman A, Watson K, Symmons D (2004) Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 63:1538–1543
35. Hitchon C, El-Gabalawy H (2004) Oxidation in rheumatoid arthritis. Arthritis Res Ther 6:265–728
36. Szodoray P, Jellestad S, Nakken B, Jg Brun, Jonsson R (2003) Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Lab Invest 83:1839–1848
37. Smith M, Weedon H, Papangelis V, Walker J, Roberts-Thomson P, Ahern M (2010) Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment. Rheumatology 49:862–875